Latest news
Loading news…
Rarecells
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Paris, Ile-de-France, France Founded 2010 11-50 employees For Profit
Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
9
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 36
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Testing
- IT spend
- $301K
Company Info
- Founded
- 2010
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 12
- HQ
- Paris, Ile-de-France, France
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.6
- Trend (90d)
- -0.1
- Last leadership hire
- Jun 18, 2025
Key People at Rarecells
Deputy CEO
Chief Operating Officer
Founder and President
9
professional contacts at Rarecells
Contact execs at Rarecells →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Rarecells
Loading news…
FAQs about Rarecells
People who checked this page also checked these
Browse the full Acquirezy directory.